|
| [February 04, 2010] |
 |
Tennessee Reproductive Medicine to Offer IntegraMed® Attain™ IVF Program to Fertility Patients
CHATTANOOGA, Tenn. --(Business Wire)--
IntegraMed America, Inc. (NASDAQ: INMD), the nation's leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, announced today that Tennessee Reproductive Medicine will begin offering IntegraMed's Attain™ IVF programs, course-of-treatment financing programs that improve patient success rates with in vitro fertilization (IVF) fertility treatments.
The Attain IVF programs, pioneered by IntegraMed, consisting of an Attain IVF Refund Program and an Attain IVF Multi-cycle Program, offer IVF patients an attractive alternative to better manage the financial commitment associated with undergoing IVF treatment. For a discounted, fixed up-front cost, the Attain IVF Refund Program provides patients with a series of six IVF treatments while refunding of up to 70% of their fees if their treatments do not result in having a baby, or 100% if donor egg cycles do not result in having a baby. The Attain IVF Multi-Cycle Program also offers a discounted, fixed up-front cost for a series of four IVF treatments.
The Attain IVF programs offer an opportunity for IVF patients to increase significantly their chances of success by allowing them to stay in treatment longer. For more information about the Attain IVF Programs please visit www.attainivf.com.
Tennessee Reproductive Medicine is located at 6031 Shallowford Drive, Suite 101, in Chattanooga, TN, and is the medical practice of Ringland (Rink) Murray, MD and Jessica Scotchie, MD. This state-of-the-art facility offers couples individualized infertility treatment plans in a caring environment. The facility includes a comprehensive assisted reproductive technology (ART) laboratory, providing the ability to undertake highly complex procedures with techniques such as ICSI, assisted hatching and embryo biopsy. For more information please visit www.trmbaby.com.
Dr. Murray commented, "Dr. Scotchie and I are both very pleased that Tennessee Reproductive Medicine will now be able to offer our patients the Attain IVF Programs of fertility financing solutions. We are keenly aware of the physical, emotional and financial commitments on our IVF patients and we are happy to do anything we can do to help mitigate that burden."
Dr. Murray, a native of Chattanooga, has had a distinguished career practicing medicine and possesses strong operational, project-management, team-building, and leadership skills. After attending medical school at the University of Tennessee Health Science Center in Memphis, Dr. Murray completed his residency in Obstetrics and Gynecology followed by a fellowship in Reproductive Endocrinology and Infertility at the University of North Carolina at Chapel Hill. Dr. Murray has received numerous awards from hospital staff, patients and residents for his dedication to teaching and delivering outstanding, compassionate and ethical care. Dr. Murray has spent the past few years with Fertility Associates of Memphis, where he maintained a busy practice, specializing in endocrine disorders and infertility. For the past two years, he has been elected into America's Best Doctors.
Dr. Scotchie has also held numerous leadership positions throughout her career and presented her prior research at international fertility conferences. Dr. Scotchie attended medical school at the University of Florida and completed a residency in Obstetrics and Gynecology and a fellowship in Reproductive Endocrinology and Infertility at the University of North Carolina at Chapel Hill. Throughout her training, Dr. Scotchie received numerous awards including being elected into Alpha Omega Alpha, the medical honor society, teaching awards from the medical students at the University of North Carolina, a research award for her resident research project, and the Housestaff Officer Award given to 5 of 700+ residents annually for exceptional and compassionate patient care.
"Offering the Attain IVF Program at Tennessee Reproductive Medicine helps to further expand our program's presence in the greater Tennessee area, an area which we feel affords strong growth opportunities," said Pamela Schumann, President of the Consumer Services Division of IntegraMed. "We look forward to providing these value-added options to patients of Tennessee Reproductive Medicine, and look ahead to working together with Drs. Murray and Scotchie to achieve great success from this relationship."
About IntegraMed America, Inc.
IntegraMed America, Inc. manages highly specialized outpatient facilities in emerging, technology-based, niche medical markets and is the leading manager of fertility centers and vein clinics in the United States. IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management and quality assurance services. IntegraMed also offers treatment-financing programs for self-pay patients.
IntegraMed's fertility network is the nations largest fertility network, comprised of 39 contracted centers with over 120 locations in 34 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. is performed in an IntegraMed network fertility practice. The IntegraMed Vein Clinic network is the leading provider of varicose vein care services in the US, currently operating 34 centers in 13 states, principally in the Midwest and Southeast.
For more information about IntegraMed please visit:
www.integramed.com for investor background,
www.integramedfertility.com for fertility, or
www.veinclinics.com for vein care
Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed are forward-looking statements that may involve a number of risks and uncertainties. Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with IntegraMed's ability to identify, consummate and finance future growth, including larger-scale acquisitions; changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the company's most recent Form 10-K and in other documents filed by IntegraMed with the U.S. Securities and Exchange Commission. All information in this press release is as of February 4, 2010, and IntegraMed undertakes no duty to update this information.
[ Back To MobilityTechzone Homepage's Homepage ]
|
COMMUNITIES
Technology Marketing Corp. 1997-2011 Copyright. | Ph: 800-243-6002, 203-852-6800; Fx: 203-853-2845 | Contact us 